CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES

• 收藏
• 分享

专利权人:

PORTOLA PHARMACEUTICALS; INC.

发明人:

PANDEY, ANJALI,COFFEY, GREGORY,LEEDS, JANET

申请号：

CA2987324

公开号：

CA2987324A1

申请日:

2016.05.27

申请国别(地区):

CA

年份:

2016

代理人:

摘要：

Provided herein are compositions and methods for treating a relapsed or refractory hematologic cancer in a human patient in need thereof. The methods entail administering to the patient a daily dose of about 10 mg to about 75 mg of cerdulatinib or a pharmaceutically acceptable salt thereof, wherein the patients suffer one or more of a B-cell malignancy, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL) or other transformed FL and/or have relapsed or not responded to a prior chemotherapy.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/